NADPH oxidase and endothelial cell function

Clinical Science

Volumn 109, Issue 3, 2005, Pages 217-226

  Ray, Robin ^a   Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelium; NADPH oxidase; Nitric oxide; Reactive oxygen species; Redox signalling

Indexed keywords

ANGIOTENSIN; ANTIOXIDANT; ASCORBIC ACID; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GLUCOSE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PROTEIN KINASE C; PROTEIN P47; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL GROWTH; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; ENZYME SUBUNIT; HEART FAILURE; HUMAN; HYPERTENSION; HYPERTROPHY; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 25144453937     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050067     Document Type: Review

References (81)

1. Cai, H. and Harrison, D. G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844
2. Shah, A. M. (1996) Paracrine modulation of heart cell function by endothelial cells. Cardiovasc. Res. 31, 847-867
3. Halcox, J. P., Schenke, W. H., Zalos, G. et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653-658
4. Fichtlscherer, S., Breuer, S. and Zeiher, A. M. (2004) Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the 'vulnerable' patient. Circulation 110, 1926-1932
5. Li, J. M. and Shah, A. M. (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 287, R1014-R1030
6. Droge, W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95
7. Dhalla, N. S., Temsah, R. M. and Netticadan, T. (2000) Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18, 655-673
8. Faraci, F. M. and Didion, S. P. (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler., Thromb., Vasc. Biol. 24, 1367-1373
9. Beckman, K. B. and Ames, B. N. (1998) The free radical theory of aging matures. Physiol. Rev. 78, 547-581
10. Fleming, I. (2001) Cytochrome P450 and vascular homeostasis. Circ. Res. 89, 753-762
11. Duchen, M. R. (2004) Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol. Aspects Med. 25, 365-451
12. Meneshian, A. and Bulkley, G. B. (2002) The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 9, 161-175
13. Channon, K. M. and Guzik, T. J. (2002) Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J. Physiol. Pharmacol. 53, 515-524
14. Landmesser, U., Dikalov, S., Price, S. R. et al. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209
15. Babior, B. M., Lambeth, J. D. and Nauseef, W. (2002) The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342-344
16. DeLeo, F. R. and Quinn, M. T. (1996) Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J. Leukocyte Biol. 60, 677-691
17. Lassegue, B. and Clempus, R. E. (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 285, R277-R297
18. Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D. and Alexander, R. W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148
19. Bayraktutan, U., Blayney, L. and Shah, A. M. (2000) Molecular characterization and localization of the NAD(P)H oxidase components gp91-phoz and p22-phox in endothelial cells. Arterioscler., Thromb., Vasc. Biol. 20, 1903-1911
20. Gorlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F. and Busse, R. (2000) A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87, 26-32
21. Phox: beyond the endothelium. Circ. Res. 87, 1-3
22. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105, 293-296
23. Lambeth, J. D. (2004) NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189
24. Suh, Y. A., Arnold, R. S., Lassegue, B. et al. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature (London) 401, 79-82
25. Cheng, G., Cao, Z., Xu, X., van Meir, E. G. and Lambeth, J. D. (2001) Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131-140
26. phox participate in activation of superoxide-producing NADPH oxidases. J. Biol. Chem. 278, 25234-25246
27. Ambasta, R. K., Kumar, P., Griendling, K. K., Schmidt, H. H., Busse, R. and Brandes, R. P. (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279, 45935-45941
28. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276, 37594-37601
29. phox. J. Biol. Chem. 279, 34250-34255
30. Banfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M. and Krause, K. H. (2004) NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 279, 46065-46072
31. Banfi, B., Clark, R. A., Steger, K. and Krause, K. H. (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510-3513
32. Jones, S. A., O'Donnell, V. B., Wood, J. D., Broughton, J. P., Hughes, E. J. and Jones, O. T. (1996) Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271, H1626-H1634
33. Li, J. M. and Shah, A. M. (2001) Differential NADPH-versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc. Res. 52, 477-486
34. Li, J. M. and Shah, A. M. (2002) Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277, 19952-19960
35. Ago, T., Kitazono, T., Ooboshi, H. et al. (2004) Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109, 227-233
36. phox subunit. J. Biol. Chem. 278, 12094-12100
37. Mollnau, H., Wendt, M., Szocs, K. et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90, E58-E65
38. Duerrschmidt, N., Wippich, N., Goettsch, W., Broemme, H. J. and Morawietz, H. (2000) Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem. Biophys. Res. Commun. 269, 713-717
39. phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91, 1160-1167
40. Frey, R. S., Rahman, A., Kefer, J. C., Minshall, R. D. and Malik, A. B. (2002) PKCzeta regulates TNF-α-induced activation of NADPH oxidase in endothelial cells. Circ. Res. 90, 1012-1019
41. phox in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-α. Circ. Res. 90, 143-150
42. Kashiwagi, A., Shinozaki, K., Nishio, Y. et al. (1999) Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am. J. Physiol. 277, E976-E983
43. Inoguchi, T., Li, P., Umeda, F. et al. (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939-1945
44. Wautier, M. P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M. and Wautier, J. L. (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 280, E685-E694
45. Rueckschloss, U., Galle, J., Holtz, J., Zerkowski, H. R. and Morawietz, H. (2001) Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104, 1767-1772
46. Hwang, J., Ing, M. H., Salazar, A. et al. (2003) Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ. Res. 93, 1225-1232
47. Kim, K. S., Takeda, K., Sethi, R. et al. (1998) Protection from reoxygenation injury by inhibition of rac1. J. Clin. Invest. 101, 1821-1826
48. Lopes, N. H., Vasudevan, S. S., Gregg, D. et al. (2002) Rac-dependent monocyte chemoattractant protein-1 production is induced by nutrient deprivation. Circ. Res. 91, 798-805
49. phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J. Biol. Chem. 278, 47291-47298
50. phox phosphorylation and binding to TRAF4. Mol. Cell Biol. 25, 2320-2330
51. - production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109, 1307-1313
52. Gregg, D., Rauscher, F. M. and Goldschmidt-Clermont, P. J. (2003) Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am. J. Physiol. Cell Physiol. 285, C723-C734
53. 2+ stores to inositol 1, 4, 5-trisphosphate in human endothelial cells. J. Biol. Chem. 275, 15749-15757
54. 2 and TNF-α and its effects on ICAM-1 expression in endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L302-L311
55. Weber, C., Erl, W., Pietsch, A., Strobel, M., Ziegler-Heitbrock, H. W. and Weber, P. C. (1994) Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler., Thromb., Vasc. Biol. 14, 1665-1673
56. Godin, C., Caprani, A., Dufaux, J. and Flaud, P. (1993) Interactions between neutrophils and endothelial cells. J. Cell. Sci. 106, 441-451
57. Chen, X. L., Zhang, Q., Zhao, R., Ding, X., Tummala, P. E. and Medford, R. M. (2003) Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells. J. Pharmacol. Exp. Ther. 305, 573-580
58. Stokes, K. Y., Clanton, E. C., Russell, J. M., Ross, C. R. and Granger, D. N. (2001) NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia- mduced leukocyte-endothelial cell adhesion. Circ. Res. 88, 499-505
59. Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J. F. and Michel, J. B. (2000) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress. Arterioscler., Thromb., Vasc. Biol. 20, 645-651
60. Warnholtz, A., Nickenig, G., Schulz, E. et al. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99, 2027-2033
61. -/- mice. J. Clin. Invest. 108, 1513-1522
62. Abid, M. R., Kachra, Z., Spokes, K. C. and Aird, W. C. (2000) NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 486, 252-256
63. Galle, J., Heinloth, A., Wanner, C. and Heermeier, K. (2001) Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress. Kidney Int. Suppl. 78, S120-S123
64. Li, A. E., Ito, H., Rovira, I.I. et al. (1999) A role for reactive oxygen species in endothelial cell anoikis. Circ. Res. 85, 304-310
65. Brandes, R. P. (2003) Role of NADPH oxidases in the control of vascular gene expression. Antioxid. Redox Signalling 5, 803-811
66. Griendling, K. K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501
67. Hink, U., Li, H., Mollnau, H. et al. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-E22
68. Zalba, G., Beaumont, F. J., Jose, G. S. et al. (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35, 1055-1061
69. Li, L., Fink, G. D., Watts, S. W et al. (2003) Endothelin-1 increases vascular superoxide via endothelinA-NADPH oxidase pathway in low-renin hypertension. Circulation 107, 1053-1058
70. Guzik, T. J., West, N. E., Black, E. et al. (2000) Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 86, E85-E90
71. Spiekermann, S., Landmesser, U., Dikalov, S. et al. (2003) Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107, 1383-1389
72. Guzik, T. J., Mussa, S., Gastaldi, D. et al. (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105, 1656-1662
73. Ellis, G. R., Anderson, R. A., Lang, D. et al. (2000) Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J. Am. Coll. Cardiol. 36, 1474-1482
74. Bauersachs, J., Bouloumie, A., Fraccarollo, D., Hu, K., Busse, R. and Ertl, G. (1999) Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100, 292-298
75. MacCarthy, P. A., Grieve, D. J., Li, J. M., Dunster, C., Kelly, F. J. and Shah, A. M. (2001) Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation 104, 2967-2974
76. Li, J. M., Gall, N. P., Grieve, D. J., Chen, M. and Shah, A. M. (2002) Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40, 477-484
77. Byrne, J. A., Grieve, D. J., Bendall, J. K. et al. (2003) Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93, 802-805
78. Heymes, C., Bendall, J. K., Ratajczak, P. et al. (2003) Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41, 2164-2171
79. Maack, C., Kartes, T., Kilter, H. et al. (2003) Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108, 1567-1574
80. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33
81. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J. and Sleight, P. (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 154-160